[[Image:Novavax.svg|right|250px]] 
 '''Novavax, Inc.''', is an American [[biotechnology]] company based in [[Gaithersburg, Maryland]] that creates [[vaccines]] to fight against serious infectious diseases. Before to 2020, company scientists developed experimental vaccines for [[Ebola]], [[influenza]], [[respiratory syncytial virus]] (RSV), and other emerging infectious diseases.  
 
 During 2020, however, the company redirected its efforts to focus on development and approval of a vaccine for [[COVID-19]]. < ref > Novavax Inc. [https://www.novavax.com/sites/default/files/2021-05/NVAX_2020_Annual_Report_FINAL.pdf 2020 Annual Report] {{Webarchive|url=https://web.archive.org/web/20210814001719/https://www.novavax.com/sites/default/files/2021-05/NVAX_2020_Annual_Report_FINAL.pdf |date=2021-08-14 }}. Accessed 10 May 2021. < /ref > 
 
 ==References== 
 {{reflist}} 
 
 {{Multistub|US|med}} 
 
 [[Category:20th-century establishments in Maryland]] 
 [[Category:1987 establishments in the United States]] 
 [[Category:Companies based in Maryland]] 
 [[Category:Montgomery County, Maryland]] 
 [[Category:Biotechnology companies of the United States]]